Bioclinica, Inc.
211 Carnegie Center Drive
Princeton, NJ 08540
United States
179 articles about Bioclinica, Inc.
-
Bioclinica Adds eConsent Functionality to Its Electronic Data Capture and Management Suite of Products
6/8/2021
Bioclinica, an ERT company, announced the addition of eConsent as part of its Electronic Data Capture and Management suite of products.
-
Bioclinica Earns CRO Leadership Awards Fourth Consecutive Year
5/24/2021
Bioclinica, an ERT company, today announced receiving 2021 CRO Leadership Awards for four consecutive years in multiple performance categories.
-
Bioclinica Announces Breakthrough AI Image Redaction Technology for Clinical Trials
1/19/2021
New solution offers pharmaceutical and biotech companies a powerful tool for video, photo, and PDF redaction, ensuring compliance and patient privacy
-
Bioclinica Acquires Saliency to Accelerate Digital Diagnostic Development
1/6/2021
New AI integration dramatically speeds medical image interpretation and model creation within Bioclinica's imaging platform
-
Robert R. Ford, MD, Returns to Bioclinica
10/13/2020
Bioclinica, an integrated solutions provider of clinical life science and technology expertise, delivering powerful insight into clinical trial development in bringing new therapies to people worldwide, announced that Robert R. Ford, MD, will join the staff as Senior Advisor, Chief Medical Officer Emeritus.
-
Bioclinica's Michael O'Neal, MD, Takes on Newly Expanded Chief Medical Officer Role
10/1/2020
- Bioclinica, an integrated solutions provider of clinical life science and technology expertise, delivering powerful insight into clinical trial development in bringing new therapies to people worldwide, today announced a new, unified Medic
-
Bioclinica Partners with Direct Biologics to Provide Interactive Response Technology (IRT) Solution for COVID-19 Study
9/9/2020
Bioclinica's IRT reduces the average setup time 50 to 75 percent for each new study compared to IRT systems built from the ground up
-
Bioclinica Appoints Dan Gebow, PhD, as Chief Innovation Officer to Lead New Strategic Effort
8/20/2020
In the new role, Dr. Gebow will advance software development and data analytics innovation across Medical Imaging and Clinical Adjudication
-
Bioclinica's Joyce Suhy, Ph.D. Honored on 2020 PharmaVOICE 100 List
8/3/2020
Bioclinica, a leading provider of clinical science and technology expertise supporting the life science industry in bringing new therapies to market, announced today that Joyce Suhy, Ph.D., Senior Vice President of Medical Imaging, is recognized by PharmaVOICE as one of the 100 most inspiring people in the life-sciences industry.
-
Bioclinica Announces Comprehensive COVID-19 Clinical Endpoint Adjudication Solution
5/7/2020
Bioclinica, a leading provider of clinical science and technology expertise to assist the life science industry, today announced a specialized program for the adjudication of adverse events that could result from COVID-19 infection. Bioclinica's new program provides an out-of-the-box Clinical Endpoint Committee solution. This solution c
-
Charles Bodner Joins Bioclinica as Chief Operating & Financial Officer Maureen Marchek Promoted to Senior Vice President
2/25/2020
Bioclinica announced that Charles "Chuck" Bodner has joined the company as Executive Vice President, Chief Operating and Financial Officer.
-
Bioclinica Announces Additions to Software Solutions Leadership
1/14/2020
Guy Crossley Named President, Software Solutions
-
Bioclinica Announces Senior Leadership Change
12/20/2019
Bioclinica, a leading provider of clinical science and technology expertise to assist the life science industry, today announces that David Herron, Bioclinica's President and Chief Executive Officer, will be leaving the company to pursue other business interests.
-
PPD’s Accelerated Enrollment Solutions Acquires Global Site Business From Bioclinica
9/5/2019
Addition of clinical research sites advances AES’ strategy of becoming the world’s largest patient access and site conduct organization
-
For years, companies have struggled to develop treatments for non-alcoholic fatty liver disease (NAFLD), a disease that is growing across the world and is predicted to become the main cause of chronic liver problems and the need for liver transplantation.
-
Bioclinica Launches NAFLD/NASH Clinical Trials Practice
4/18/2019
Bioclinica®, a leading provider of science and technology expertise to assist the life science industry in advancing the development of medical therapies, announced today that it has assembled a team of experts dedicated to nonalcoholic fatty liver disease (NAFLD) and its more advanced form, nonalcoholic steatohepatitis (NASH), to help sponsors develop therapeutics using medical imaging and other biomarkers in clinical trials.
-
Bioclinica Appoints David Herron as CEO
12/1/2017
With more than 10 years' of experience at Bioclinica, David Herron has led the company’s Medical Imaging business to great success
-
Bioclinica Launches Clinical Adjudication Led by Experienced Medical Specialists and Researchers for Enhanced Safety and Efficacy in Clinical Trials
12/1/2017
The new service enables the independent adjudication of clinical events in conformance with regulatory requirements governing clinical trials within all therapeutic areas, including cardiac studies and for MACE committees.
-
Bioclinica Acquires MDDX Research & Informatics Combining Advanced Image Management Cloud Technology With its Scientific and Medical Imaging Leadership
11/7/2017
With the acquisition comes MDDX's best-in-class, cloud-based image submission technology, which will become the backbone of Bioclinica's SMART solution.
-
Bioclinica Moves To New Princeton, New Jersey Office In Response To Growth
10/4/2017